Western blotting evaluation of HCC samples and matched non-tumor tissue samples demonstrates that OPA1 expression is decreased in up to 40% of HCC patients (Legros et al., 2004), suggesting important roles for OPA1 in the development of HCC. Here, OPA1 is linked to hepatocellular carcinoma.